At the University of São Paulo's Center for Research in Bacterial and Bacteriophage Biology, researchers have just unveiled a hidden arsenal: 45 previously unknown toxins produced by Salmonella bacteria, each one a potential key to understanding how pathogens wage molecular warfare and how we might one day defeat them.
This discovery matters because Salmonella remains one of the world's most common causes of foodborne illness, yet we've understood only a fraction of the bacterial weapons at its disposal. The team, led by bioinformatician Robson Francisco de Souza, set out to map the full scope of these toxins by examining the bacterium's "type VI secretion system"—essentially a spear-like injection apparatus that Salmonella uses to pierce rivals and pump toxins into competing microorganisms or host cells. What they found was staggering in its diversity.
Using computational analysis, the researchers examined genetic material from 6,165 Salmonella samples representing 149 different serovars, or bacterial subtypes. In total, they identified 128 types of toxins, meaning that the 45 newly discovered ones nearly doubled our understanding of Salmonella's toxic repertoire in one stroke. "This result implies that the diversity of bacterial toxins and antitoxins worldwide is very high, with new varieties emerging or diverging radically from known related variants," Souza explained. The newly identified molecules act in strikingly different ways: some are biological mercenaries deployed against competing bacteria, while others target eukaryotic cells—the kind found in fungi, yeasts, algae, and mammals, potentially including us.
The research reveals that Salmonella doesn't carry all toxins indiscriminately. Instead, each bacterial group maintains a unique combination of effectors, a signature arsenal shaped by the specific environmental pressures it faces. Even more intriguingly, Salmonella collected from natural environments—where microbial competition is fierce and varied—carry significantly more toxins than strains isolated from infected patients. "This happens because, as new challenges and adversaries emerge, the microorganism needs to develop new tools to excel in these disputes over resources," Souza notes. It's an evolutionary arms race written in genes, where each new competitor spawns new countermeasures.
The implications extend far beyond academic curiosity. These newly mapped toxins could serve as blueprints for developing novel antibiotics at a time when antibiotic resistance is becoming critical. Some may inspire entirely new biotechnological applications—Souza points out that important eukaryotic proteins have originated from bacterial toxins in evolutionary history, suggesting these compounds could play unexpected roles in medicine and biotechnology. Yet confirming whether specific Salmonella toxins directly fuel human infections will require the next phase of research: isolating the strains that target our cells and experimentally testing their effects.
The field is far from complete. Souza and his team are already expanding their investigation beyond Salmonella to Acinetobacter and other bacteria, and even to archaea—ancient organisms that remain largely unexplored for their toxin diversity. As they develop new software pipelines to automate the search, they expect discoveries to accelerate. For now, this single study has shown us that the molecular world remains full of surprises, and that understanding bacterial competition strategies may unlock tools we can barely imagine yet.